Celcuity, Inc. (NASDAQ:CELC) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Celcuity, Inc. (NASDAQ:CELCGet Free Report) have earned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating and ten have given a buy rating to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $154.5455.

A number of equities analysts have issued reports on the company. Macquarie Infrastructure set a $160.00 target price on Celcuity in a research report on Thursday, May 28th. Craig Hallum reissued a “buy” rating and set a $178.00 price target on shares of Celcuity in a research report on Wednesday, July 15th. Stifel Nicolaus dropped their price target on shares of Celcuity from $175.00 to $150.00 and set a “buy” rating for the company in a research note on Friday, August 14th. Wells Fargo & Company cut their price target on shares of Celcuity from $183.00 to $166.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Finally, Citizens Jmp reiterated a “market outperform” rating and set a $177.00 price objective on shares of Celcuity in a research note on Monday, August 17th.

View Our Latest Research Report on CELC

Institutional Trading of Celcuity

Hedge funds and other institutional investors have recently bought and sold shares of the company. Avoro Capital Advisors LLC acquired a new stake in Celcuity during the fourth quarter valued at approximately $310,302,000. California State Teachers Retirement System grew its position in shares of Celcuity by 7,330.1% in the 2nd quarter. California State Teachers Retirement System now owns 1,900,632 shares of the company’s stock worth $198,844,000 after acquiring an additional 1,875,052 shares in the last quarter. Bank of America Corp DE bought a new stake in shares of Celcuity in the 2nd quarter valued at approximately $153,928,000. NEA Management Company LLC increased its holdings in shares of Celcuity by 64.9% in the 4th quarter. NEA Management Company LLC now owns 3,535,561 shares of the company’s stock valued at $352,637,000 after acquiring an additional 1,391,300 shares during the last quarter. Finally, State Street Corp raised its position in shares of Celcuity by 126.6% during the 4th quarter. State Street Corp now owns 1,637,687 shares of the company’s stock valued at $163,343,000 after acquiring an additional 914,887 shares in the last quarter. 63.33% of the stock is owned by institutional investors.

Celcuity Price Performance

Shares of NASDAQ CELC opened at $95.70 on Monday. Celcuity has a 1 year low of $44.42 and a 1 year high of $151.02. The firm has a market cap of $4.68 billion, a price-to-earnings ratio of -22.26 and a beta of 0.19. The company has a debt-to-equity ratio of 6.04, a quick ratio of 8.93 and a current ratio of 8.93. The stock’s 50-day simple moving average is $94.58 and its 200-day simple moving average is $106.78.

Celcuity (NASDAQ:CELCGet Free Report) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($1.44) EPS for the quarter, missing analysts’ consensus estimates of ($1.16) by ($0.28). As a group, equities analysts anticipate that Celcuity will post -4.75 earnings per share for the current fiscal year.

Celcuity Company Profile

(Get Free Report)

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.

Recommended Stories

Analyst Recommendations for Celcuity (NASDAQ:CELC)

Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.